Dr Thomas Wayne Day, MD | |
24 White Bridge Rd, Nashville, TN 37205-1411 | |
(615) 352-0011 | |
(615) 352-1752 |
Full Name | Dr Thomas Wayne Day |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 43 Years |
Location | 24 White Bridge Rd, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356410195 | NPI | - | NPPES |
6039703 | Other | TN | BCBS TN |
Q027019 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 20401 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cumberland Skin Surgery And Dermatology | 0941391338 | 54 |
Pinnacle Dermatology Sc | 8628353380 | 160 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.
Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.
Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
› Verified 6 days ago
Entity Name | Murfreesboro Dermatology Clinic Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275553703 PECOS PAC ID: 6507839503 Enrollment ID: O20040817001448 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.
Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.
Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
› Verified 6 days ago
Entity Name | Cumberland Skin Surgery And Dermatology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922138247 PECOS PAC ID: 0941391338 Enrollment ID: O20070814000893 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.
Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.
Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
› Verified 6 days ago
Entity Name | Pinnacle Dermatology Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20200401003176 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.
Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.
Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Wayne Day, MD 3810 Central Pike, Hermitage, TN 37076-3494 Ph: (931) 967-9393 | Dr Thomas Wayne Day, MD 24 White Bridge Rd, Nashville, TN 37205-1411 Ph: (615) 352-0011 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
White House Office of National Drug Control Policy Director Gil Kerlikowske today unveiled a new anti-methamphetamine ad campaign tailored for Indian Country, launched in New Mexico and in 14 other states with the largest Native American populations.
Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.
Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
› Verified 6 days ago
Dr. Eric Austin Millican, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 719 Thompson Ln, Suite 26300, Nashville, TN 37204 Phone: 615-322-0845 Fax: 615-343-3947 | |
Maria Isabel Colome, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 658 Grassmere Park, Nashville, TN 37211 Phone: 615-221-4400 | |
Dr. Nashay N Clemetson, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Lee Wheless, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 719 Thompson Lane Suite 26300, Nashville, TN 37232 Phone: 615-322-0417 | |
Eman Bahrani, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Margaret Catherine Morgan, NP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 24 White Bridge Pike, Nashville, TN 37205 Phone: 615-352-0011 | |
Jennifer Dempsey Martin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 21st Ave S, Nashville, TN 37212 Phone: 615-327-9797 Fax: 615-613-0329 |